Terms: = Lung cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Diagnosis
39 results:
1. Drug-induced interstitial lung disease: a narrative review of a clinical conundrum.
Harrison M; Kavanagh G; Corte TJ; Troy LK
Expert Rev Respir Med; 2024; 18(1-2):23-39. PubMed ID: 38501199
[TBL] [Abstract] [Full Text] [Related]
2. Intratumoral Delivery of Chimeric Antigen Receptor T Cells Targeting CD133 Effectively Treats Brain Metastases.
Kieliszek AM; Mobilio D; Upreti D; Bloemberg D; Escudero L; Kwiecien JM; Alizada Z; Zhai K; Ang P; Chafe SC; Vora P; Venugopal C; Singh SK
Clin Cancer Res; 2024 Feb; 30(3):554-563. PubMed ID: 37787999
[TBL] [Abstract] [Full Text] [Related]
3. Real-world evidence of the safety and survival with CD19 car-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
McKenna M; Epperla N; Ghobadi A; Liu J; Lazaryan A; Ibrahim U; Jacobson CA; Naik SG; Nastoupil L; Chowdhury SM; Voorhees TJ; Jacobs MT; Farooq U; Osman K; Olszewski AJ; Ahmed S; Evens AM
Br J Haematol; 2023 Jul; 202(2):248-255. PubMed ID: 37129856
[TBL] [Abstract] [Full Text] [Related]
4. Acquired crizotinib-resistant pulmonary adenocarcinoma and subsequent primary gallbladder cancer: A case report.
Zhang M; Chen R; Zheng S; Wang Z
Medicine (Baltimore); 2023 Mar; 102(11):e33162. PubMed ID: 36930086
[TBL] [Abstract] [Full Text] [Related]
5. Acceptability of a standalone written leaflet for the National Health Service for England Targeted lung Health Check Programme: A concurrent, think-aloud study.
Jallow M; Black G; van Os S; Baldwin DR; Brain KE; Donnelly M; Janes SM; Kurtidu C; McCutchan G; Robb KA; Ruparel M; Quaife SL
Health Expect; 2022 Aug; 25(4):1776-1788. PubMed ID: 35475542
[TBL] [Abstract] [Full Text] [Related]
6. Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.
Kito Y; Kawashima K; Saigo C; Hasegawa M; Nomura S; Mikamo T; Hanamatsu Y; Matsuo Y; Takeuchi T
Diagn Pathol; 2022 Feb; 17(1):29. PubMed ID: 35151345
[TBL] [Abstract] [Full Text] [Related]
7. Is the combination of bilateral pulmonary nodules and mosaic attenuation on chest CT specific for DIPNECH?
Samhouri BF; Koo CW; Yi ES; Ryu JH
Orphanet J Rare Dis; 2021 Nov; 16(1):490. PubMed ID: 34809674
[TBL] [Abstract] [Full Text] [Related]
8. Intravitreal dexamethasone implant use as first-line therapy for cancer-associated retinopathy.
Mudri J; Phagura RS; Lam WS; Wu XN
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34764094
[TBL] [Abstract] [Full Text] [Related]
9. A novel break site of EML4-ALK report and a rare prkar1a-ALK report analyzed by different ALK detection platforms in non-small cell lung cancer patients.
Du X; Zhang J; Gao H; Tai Y
Thorac Cancer; 2021 Oct; 12(20):2773-2779. PubMed ID: 34490727
[TBL] [Abstract] [Full Text] [Related]
10. diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer.
Ragoonanan D; Khazal SJ; Abdel-Azim H; McCall D; Cuglievan B; Tambaro FP; Ahmad AH; Rowan CM; Gutierrez C; Schadler K; Li S; Di Nardo M; Chi L; Gulbis AM; Shoberu B; Mireles ME; McArthur J; Kapoor N; Miller J; Fitzgerald JC; Tewari P; Petropoulos D; Gill JB; Duncan CN; Lehmann LE; Hingorani S; Angelo JR; Swinford RD; Steiner ME; Hernandez Tejada FN; Martin PL; Auletta J; Choi SW; Bajwa R; Dailey Garnes N; Kebriaei P; Rezvani K; Wierda WG; Neelapu SS; Shpall EJ; Corbacioglu S; Mahadeo KM
Nat Rev Clin Oncol; 2021 Jul; 18(7):435-453. PubMed ID: 33608690
[TBL] [Abstract] [Full Text] [Related]
11. Clinical utility of pretreatment Glasgow prognostic score in non-small-cell lung cancer patients treated with immune checkpoint inhibitors.
Takamori S; Takada K; Shimokawa M; Matsubara T; Fujishita T; Ito K; Toyozawa R; Yamaguchi M; Okamoto T; Yoneshima Y; Tanaka K; Okamoto I; Tagawa T; Mori M
Lung Cancer; 2021 Feb; 152():27-33. PubMed ID: 33341085
[TBL] [Abstract] [Full Text] [Related]
12. cancer-associated retinopathy preceding the diagnosis of a pulmonary carcinoid tumour.
Merle G; Baglivo E; Younossian AB; Vijgen S; Karenovics W; Kherad O
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33139354
[TBL] [Abstract] [Full Text] [Related]
13. Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell lung cancer.
Matsubara T; Takamori S; Haratake N; Fujishita T; Toyozawa R; Ito K; Shimokawa M; Yamaguchi M; Seto T; Okamoto T
Ann Surg Oncol; 2021 Jun; 28(6):3046-3054. PubMed ID: 33084992
[TBL] [Abstract] [Full Text] [Related]
14. cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
Front Immunol; 2020; 11():1280. PubMed ID: 32849491
[TBL] [Abstract] [Full Text] [Related]
15. New vistas in malignant mesothelioma: MicroRNA architecture and NRF2/MAPK signal transduction.
Gandhi M; Nair S
Life Sci; 2020 Sep; 257():118123. PubMed ID: 32710945
[TBL] [Abstract] [Full Text] [Related]
16. Development and Validation of a Prognostic Survival Model With Patient-Reported Outcomes for Patients With cancer.
Seow H; Tanuseputro P; Barbera L; Earle C; Guthrie D; Isenberg S; Juergens R; Myers J; Brouwers M; Sutradhar R
JAMA Netw Open; 2020 Apr; 3(4):e201768. PubMed ID: 32236529
[TBL] [Abstract] [Full Text] [Related]
17. DLL3: an emerging target in small cell lung cancer.
Owen DH; Giffin MJ; Bailis JM; Smit MD; Carbone DP; He K
J Hematol Oncol; 2019 Jun; 12(1):61. PubMed ID: 31215500
[TBL] [Abstract] [Full Text] [Related]
18. A case of cancer-associated retinopathy with chorioretinitis and optic neuritis associated with occult small cell lung cancer.
Carrera W; Tsamis KA; Shah R
BMC Ophthalmol; 2019 May; 19(1):101. PubMed ID: 31046716
[TBL] [Abstract] [Full Text] [Related]
19. cancer-associated retinopathy preceding the diagnosis of cancer.
Hoogewoud F; Butori P; Blanche P; Brézin AP
BMC Ophthalmol; 2018 Nov; 18(1):285. PubMed ID: 30390655
[TBL] [Abstract] [Full Text] [Related]
20. Improvements in hospice utilization among patients with advanced-stage lung cancer in an integrated health care system.
Sullivan DR; Ganzini L; Lapidus JA; Hansen L; Carney PA; Osborne ML; Fromme EK; Izumi S; Slatore CG
Cancer; 2018 Jan; 124(2):426-433. PubMed ID: 29023648
[TBL] [Abstract] [Full Text] [Related]
[Next]
